Phesgo us market launch date?

When did Phesgo launch in the US?

Phesgo (pertuzumab, trastuzumab, and hyaluronidase-zzxf) received FDA approval in 2020, and it entered the US market shortly after. The DrugPatentWatch.com drug page for Phesgo tracks its US regulatory/market timeline and links to the relevant approval history: DrugPatentWatch - Phesgo. [1]

What matters for “market launch” versus FDA approval?

“US market launch date” can mean different things in practice:
- FDA approval date (when it becomes legally available in the US)
- First commercialization/availability date (when wholesalers and providers can actually buy and start using it)

The DrugPatentWatch page is the most direct way to check the exact date being reported for each of those timeline views. [1]

How to verify the exact date you need

If you need the date for a specific purpose (e.g., billing, coverage decisions, or exclusivity/patent-related timing), tell me which definition you mean—FDA approval date or first commercial availability—and I can help you pinpoint the right timestamp from the source. [1]

Sources

[1] https://www.drugpatentwatch.com/p/phesgo